Paradigm Biopharma (ASX: PAR)
Paradigm Biopharma (ASX: PAR) is a biopharmaceutical company focused on repurposing the drug ‘pentosan polysulphate sodium’ (PPS) for the treatment of inflammation. www.paradigmbiopharma.com
Paradigm Biopharma (ASX: PAR) is a biopharmaceutical company focused on repurposing the drug ‘pentosan polysulphate sodium’ (PPS) for the treatment of inflammation. www.paradigmbiopharma.com